Cargando…

Navigating the Expanded Access Pathway to Investigational Drugs as an Academic Oncologist

This qualitative study explores academic oncologists’ needs and satisfaction with expanded patient access to investigational drugs.

Detalles Bibliográficos
Autores principales:	Fernandez Lynch, Holly, Salam, Tasnim, Gould, Patrick, Bateman-House, Alison, Kimberly, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938427/ https://www.ncbi.nlm.nih.gov/pubmed/36800184 http://dx.doi.org/10.1001/jamanetworkopen.2023.0060

Ejemplares similares

Perspectives of Academic Oncologists About Offering Expanded Access to Investigational Drugs
por: Gould, Patrick, et al.
Publicado: (2022)

A survey of pediatric hematologists/oncologists’ perspectives on single patient Expanded Access and Right to Try
por: Chapman, Carolyn Riley, et al.
Publicado: (2021)

Expanded Access and Right To Try Requests: The Community Oncologist's Experience
por: Zettler, Marjorie E., et al.
Publicado: (2021)

Devil in the Details: Physician Duties and Expanded Access
por: Lynch, Holly Fernandez
Publicado: (2023)

Xenopus Models of Cancer: Expanding the Oncologist’s Toolbox
por: Hardwick, Laura J. A., et al.
Publicado: (2018)

Oncologists’ reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center
por: Stout, Jeremiah, et al.
Publicado: (2021)

National landscape assessment of academic medical center support for expanded access to investigational products
por: Gravelin, Misty, et al.
Publicado: (2022)

State Standards for Insurance Access to Oncologists
por: Moore, Catherine J, et al.
Publicado: (2021)

Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the “Right to Try”
por: Van Norman, Gail A.
Publicado: (2018)

Geriatric assessment for oncologists
por: Korc-Grodzicki, Beatriz, et al.
Publicado: (2015)

Expanding roles for academic entrepreneurship in drug discovery
por: Kinch, Michael S., et al.
Publicado: (2020)

The effect of cancer exemption in mandatory-access prescription drug monitoring programs among oncologists
por: Graetz, Ilana, et al.
Publicado: (2023)

Patient and Provider Perspectives on Barriers to Accessing Gynecologic Oncologists for Ovarian Cancer Surgical Care
por: Weeks, Kristin, et al.
Publicado: (2020)

1726P Expanding the role of medical oncologist in the management of COVID-19
por: Ghiglione, L., et al.
Publicado: (2020)

Results from Expanded Access Programs: A Review of Academic Literature
por: Polak, Tobias B., et al.
Publicado: (2023)

Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits
por: Fountzilas, Elena, et al.
Publicado: (2018)

Navigating the expanded access investigational new drug protocol for tecovirimat: lessons learned from a public–private hospital partnership during the 2022 NYC mpox outbreak
por: Mgbako, Ofole, et al.
Publicado: (2023)

Assessment of Differences in Academic Rank and Compensation by Gender and Race/Ethnicity Among Academic Radiation Oncologists in the United States
por: Raldow, Ann C., et al.
Publicado: (2023)

The ‘false hope’ argument in discussions on expanded access to investigational drugs: a critical assessment
por: Hordijk, Marjolijn, et al.
Publicado: (2022)

Estimated Clinical Trial Capacity of Sites Participating in the COVID-19 Convalescent Plasma Expanded Access Program
por: Gustafson, M. Sage, et al.
Publicado: (2022)

Investigation of Radiation Oncologists’ Awareness of Online Reputation Management
por: Waxer, Jonathan Fredric, et al.
Publicado: (2019)

Navigating Access and Optimizing Medication Infusions in an Academic Medical Center: A Quality Improvement Study
por: Jusufi, Herolind, et al.
Publicado: (2023)

Oncologists' perceived barriers to an expanded role for primary care in breast cancer survivorship care
por: Neuman, Heather B., et al.
Publicado: (2016)

When Do Orthopaedic Oncologists Consider the Implantation of Expandable Prostheses in Bone Sarcoma Patients?
por: Gilg, Magdalena M., et al.
Publicado: (2018)

The changing landscape of expanded access to investigational drugs for patients with unmet medical needs: ethical implications
por: Bunnik, Eline M., et al.
Publicado: (2017)

Increasing health service access by expanding disease coverage and adding patient navigation: challenges for patient satisfaction
por: Schutt, Russell K., et al.
Publicado: (2020)

Women Oncologists’ Perceptions and Factors Associated With Decisions to Pursue Academic vs Nonacademic Careers in Oncology
por: Merfeld, Emily C., et al.
Publicado: (2021)

Expanding Patient Access to Investigational New Drugs: Overview of Intermediate and Widespread Treatment Investigational New Drugs, and Emergency Authorization in Public Health Emergencies
por: Van Norman, Gail A.
Publicado: (2018)

The role of the oncologist
por: Rossi, M, et al.
Publicado: (2010)

Taking AIM at serious illness: implementing an access to investigational medicines expanded access program
por: Joly, Meghan Morrison, et al.
Publicado: (2023)

Availability of Investigational Medicines Through the US Food and Drug Administration’s Expanded Access and Compassionate Use Programs
por: Puthumana, Jeremy, et al.
Publicado: (2018)

Pharmacists expand access to reproductive heaLthcare: PEARL study protocol
por: Rodriguez, Maria I., et al.
Publicado: (2019)

Investigation and analysis of oncologists’ knowledge of morphine usage in cancer pain treatment
por: Liu, Weiran, et al.
Publicado: (2014)

The Role of Physicians in Expanded Access to Investigational Drugs: A Mixed-Methods Study of Physicians’ Views and Experiences in The Netherlands
por: Bunnik, Eline M., et al.
Publicado: (2021)

Do Physicians Have a Duty to Discuss Expanded Access to Investigational Drugs with their Patients? A Normative Analysis
por: Vermeulen, Stefan F., et al.
Publicado: (2023)

Adapting an Expanded Access program to enable investigational treatments for COVID-19
por: Samuels, Elias, et al.
Publicado: (2022)

Access to care issues adversely affect breast cancer patients in Mexico: oncologists’ perspective
por: Chavarri-Guerra, Yanin, et al.
Publicado: (2014)

Awareness of predatory journals and open access among medical oncologists: results of an online survey
por: Richtig, Georg, et al.
Publicado: (2019)

Factor Analysis of Health Care Access With Ovarian Cancer Surgery and Gynecologic Oncologist Consultation
por: Gupta, Anjali, et al.
Publicado: (2023)

Delamanid expanded access novel treatment of drug resistant tuberculosis
por: Rustomjee, Roxana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sgi0kac7u2tngk9pclng3q8s8e